Safety and efficacy of Ovaleap® (recombinant human follicle-stimulating hormone) for up to 3 cycles in infertile women using assisted reproductive technology: a phase 3 open-label follow-up to Main Study

BACKGROUND: Ovaleap® (follitropin alfa), a recombinant human follicle-stimulating hormone intended for use in controlled ovarian stimulation in women undergoing assisted reproductive technologies (ART), showed therapeutic equivalence to Gonal-f® in a multinational, multicenter, randomized, controlle...

Descripción completa

Detalles Bibliográficos
Autores principales: Strowitzki, Thomas, Kuczynski, Waldemar, Mueller, Arnd, Bias, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902897/
https://www.ncbi.nlm.nih.gov/pubmed/27287439
http://dx.doi.org/10.1186/s12958-016-0164-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902897/
https://www.ncbi.nlm.nih.gov/pubmed/27287439
http://dx.doi.org/10.1186/s12958-016-0164-y

Ejemplares similares